H.‐P. Kruse

1.6k total citations
73 papers, 1.1k citations indexed

About

H.‐P. Kruse is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, H.‐P. Kruse has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 16 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in H.‐P. Kruse's work include Bone health and treatments (16 papers), Bone health and osteoporosis research (15 papers) and Parathyroid Disorders and Treatments (12 papers). H.‐P. Kruse is often cited by papers focused on Bone health and treatments (16 papers), Bone health and osteoporosis research (15 papers) and Parathyroid Disorders and Treatments (12 papers). H.‐P. Kruse collaborates with scholars based in Germany, United States and France. H.‐P. Kruse's co-authors include Harshadrai M. Rawel, Sascha Rohn, Jürgen Kröll, D. de Wied, Mostafa Ali, F. Kuhlencordt, Thomas Homann, Mahmoud Khalil, Sabine E. Kulling and Peter Winterhalter and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Food Chemistry and Metabolism.

In The Last Decade

H.‐P. Kruse

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.‐P. Kruse Germany 15 330 262 191 180 139 73 1.1k
Snežana B. Pajović Serbia 21 330 1.0× 56 0.2× 61 0.3× 18 0.1× 149 1.1× 93 1.4k
Mariano Intrieri Italy 19 429 1.3× 35 0.1× 48 0.3× 76 0.4× 129 0.9× 51 1.3k
Linjing Zhao China 16 863 2.6× 106 0.4× 97 0.5× 20 0.1× 97 0.7× 22 1.3k
Paolo Spinella Italy 20 324 1.0× 41 0.2× 18 0.1× 41 0.2× 75 0.5× 70 1.3k
Xianrong Xu China 18 323 1.0× 60 0.2× 36 0.2× 15 0.1× 117 0.8× 79 1.2k
Daisuke Kobayashi Japan 25 644 2.0× 24 0.1× 688 3.6× 14 0.1× 84 0.6× 76 2.2k
Jinghua Zhang China 15 311 0.9× 46 0.2× 55 0.3× 12 0.1× 56 0.4× 57 930
Tatsuhiko Ito Japan 24 372 1.1× 88 0.3× 60 0.3× 6 0.0× 46 0.3× 52 1.7k
Istvan Szelenyi Germany 24 549 1.7× 63 0.2× 93 0.5× 5 0.0× 125 0.9× 129 1.8k
H. Heinle Germany 20 444 1.3× 37 0.1× 93 0.5× 5 0.0× 70 0.5× 79 1.4k

Countries citing papers authored by H.‐P. Kruse

Since Specialization
Citations

This map shows the geographic impact of H.‐P. Kruse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.‐P. Kruse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.‐P. Kruse more than expected).

Fields of papers citing papers by H.‐P. Kruse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.‐P. Kruse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.‐P. Kruse. The network helps show where H.‐P. Kruse may publish in the future.

Co-authorship network of co-authors of H.‐P. Kruse

This figure shows the co-authorship network connecting the top 25 collaborators of H.‐P. Kruse. A scholar is included among the top collaborators of H.‐P. Kruse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.‐P. Kruse. H.‐P. Kruse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schnabel, Claudia, Kimberly Jett, Jan M. Friedman, et al.. (2012). Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: A retrospective clinical study. Joint Bone Spine. 80(3). 315–319. 16 indexed citations
2.
Ringe, J. D., et al.. (2009). Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis. Drugs & Aging. 26(3). 241–253. 11 indexed citations
3.
Kruse, H.‐P., et al.. (2008). Die einheimische Sprue, oft verkannte Ursache hochgradiger generalisierter Osteopathien*. DMW - Deutsche Medizinische Wochenschrift. 112(30). 1155–1159. 2 indexed citations
4.
Fardellone, Patrice, C. Roux, J. Fechtenbaum, et al.. (2005). Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women whatever the baseline vertebral fracture status. Open Repository and Bibliography (University of Liège). 1 indexed citations
5.
Brecht, Josef Georg, et al.. (2004). Health-economic comparison of three recommended drugs for the treatment of osteoporosis.. PubMed. 24(1). 1–10. 33 indexed citations
6.
Brecht, Josef Georg, et al.. (2003). Pharmacoeconomic analysis of osteoporosis treatment with risedronate.. PubMed. 23(4). 93–105. 21 indexed citations
7.
Meunier, Pierre J., R Lorenc, Ian Smith, et al.. (2002). Strontium ranelate: new efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women. Open Repository and Bibliography (University of Liège). 7 indexed citations
8.
Kudlacek, Stefan, et al.. (2001). On the prevention of osteoporosis. DMW - Deutsche Medizinische Wochenschrift. 126(27). 793–797.
9.
Kruse, H.‐P.. (2001). Can satiety be measured?. Food / Nahrung. 45(4). 298–301. 2 indexed citations
10.
Kemper, Markus J., et al.. (2001). Bone mineral density in children with primary hyperoxaluria type I. Nephrology Dialysis Transplantation. 16(11). 2236–2239. 20 indexed citations
11.
Ge, Zhong, H.‐P. Kruse, & Jerrold E. Marsden. (1996). The limits of hamiltonian structures in three-dimensional elasticity, shells, and rods. Journal of Nonlinear Science. 6(1). 19–57. 7 indexed citations
12.
Roux, Christian, C. Gennari, Jordi Farrerons, et al.. (1995). Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of bone. Arthritis & Rheumatism. 38(6). 851–858. 98 indexed citations
13.
Kruse, H.‐P., et al.. (1994). Characterization of fat replacers. European Food Research and Technology. 199(4). 285–288. 1 indexed citations
14.
Kruse, H.‐P.. (1992). Flüssigkeitstropfen zwischen parallelen Platten : Hamiltonsche Struktur, Existenz von Lösungen und Stabilität. 1 indexed citations
15.
Kuhlencordt, F. & H.‐P. Kruse. (1987). Case report 422. Skeletal Radiology. 16(5). 407–411.
16.
Kruse, H.‐P. & W. Rödel. (1982). Fleischaroma. 3. Mitt. Instrumental‐analytische und sensorische Charakterisierung von Dithiazin‐Derivaten. Food / Nahrung. 26(4). 369–376. 1 indexed citations
17.
Kruse, H.‐P., et al.. (1980). Trennung und Identifizierung der cis/trans‐Isomeren von 3,5‐Di‐n‐alkyl‐1,2,4‐trithiolanen. Zeitschrift für Chemie. 20(2). 65–66. 1 indexed citations
18.
Kuhlencordt, F., et al.. (1977). [Albers-Schoenberg osteopetrosis, a clinical and osteologic, nuclear medicine and genetic family study].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39. 135–60. 1 indexed citations
19.
Kuhlencordt, F., et al.. (1967). Vergleichende röntgenologische und morphometrische Untersuchungen bei der Osteoporose. Journal of Molecular Medicine. 45(20). 1020–1023. 3 indexed citations
20.
Friedrich, E & H.‐P. Kruse. (1964). [ON THE DERMATOPHYTE FLORA OF HALLE].. PubMed. 15. 358–62. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026